06.01.2021 - 10:00: eleva GmbH [
newsroom]
Freiburg (ots) - Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further ...
To the press release of eleva GmbH